drugset / Trial / NCT01458210
A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to look at how the body processes oral contraceptive (OC), using Ortho-Cyclen, as a commonly prescribed combination oral contraceptive in healthy female participants, and the effect of dulaglutide on how Ortho-Cyclen is processed by the body. Information about any side effects that may occur will also be collected.
Timeline
- Start
- 2011-10
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dulaglutide | Peptide | 1.5 mg | Subcutaneous |
| Subject | Ortho-Cyclen | Unknown | 0.035 mg | Oral |
| Subject | Ortho-Cyclen | Unknown | 0.25 mg | Oral |